Every 8-K that LATAMED AI CORP (LMED) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow LMED and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LMED filings page.
LataMed AI Corp. reports that, effective August 11, 2026, its common stock resumed trading under its permanent trading symbol “LMED”. This follows the expiration of the temporary symbol “LMEDD”, which had been used in connection with the company’s previously announced five-for-one (5-for-1) forward stock split. The common stock continues to trade on the OTC Markets under the LMED symbol.
LataMed AI Corp. is implementing a 5-for-1 forward stock split that became effective at the opening of trading after its corporate action appeared on the FINRA Daily List dated July 14, 2026. Common stock now trades under temporary symbol LMEDD with a “D” suffix expected for approximately twenty business days before reverting to LMED.
The split is tied to a mandatory share exchange and a new CUSIP number 21116R404, with the prior CUSIP 21116R305 suspended upon effectiveness. Shares held in brokerage or book-entry form are expected to adjust automatically, while holders of physical certificates will receive the appropriate number of post-split shares when they submit certificates through the transfer agent.
The company continues to focus on expanding its telemedicine platform and commercializing its CardioAI, PulmoAI, and NeuroAI healthcare AI solutions, initially targeting Latin American markets.
LATAMED AI Corp. amended its Nevada charter to significantly expand its capital structure and split its stock. Authorized common stock increased from 700,000,000 shares to 3,500,000,000 shares, par value $0.0001 per share, and authorized preferred stock increased from 300,000,000 shares to 1,500,000,000 shares, par value $0.0001 per share. The change also effected a five-for-one forward split of issued and outstanding common shares, reclassifying each one share into five shares of common stock.